Plasma Brain-Derived Neurotrophic Factor (BDNF) and serum cortisol levels in a sample of workers exposed to occupational stress and suffering from Adjustment Disorders.


Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
07 2019
Historique:
received: 12 11 2018
revised: 05 03 2019
accepted: 03 04 2019
pubmed: 15 6 2019
medline: 14 3 2020
entrez: 15 6 2019
Statut: ppublish

Résumé

Decreased plasma BDNF (pBDNF) levels have been proposed as a biomarker in illness phases of mood disorders. Serum cortisol (seC) levels are an index of energy mobilization and stress. The aim of this cross-sectional study was to evaluate pBDNF and seC levels in workers exposed to occupational stress and suffering from Adjustment Disorders (AD) compared to healthy workers. Plasma BDNF and seC levels were measured by means of specific immunoassays in 64 AD patients and 38 healthy controls. Perceived and occupational stress was evaluated in patients and controls using the Psychological Stress Measure (PSM) and the Job Content Questionnaire (JCQ). Psychopatological symptoms in patients were assessed using specific rating scales. Plasma BDNF levels resulted significantly higher in patients than in controls, whereas no significant differences were found for seC levels. In patients but not in controls pBDNF levels showed a significant positive correlation with seC levels. Perceived stress levels were positively correlated with all psychopatological rating scales scores. BDNF could play a key role in the pathophysiology of stress-related disorders and its peripheral levels elevation could contribute to protect neurons under stress. Further research is needed focusing on biomarkers for stress-related disorders as a potential tool for the diagnosis and prevention of occupational diseases.

Identifiants

pubmed: 31197968
doi: 10.1002/brb3.1298
pmc: PMC6625476
doi:

Substances chimiques

Biomarkers 0
Brain-Derived Neurotrophic Factor 0
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e01298

Informations de copyright

© 2019 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.

Références

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):679-85
pubmed: 18160197
Adv Med Sci. 2018 Mar;63(1):192-198
pubmed: 29175078
F1000Prime Rep. 2013 May 01;5:13
pubmed: 23710327
Med Lav. 2016 Mar 24;107(2):92-101
pubmed: 27015025
PLoS One. 2014 Apr 22;9(4):e96025
pubmed: 24755878
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1459-65
pubmed: 18541357
Ann Behav Med. 1998 Spring;20(2):84-91
pubmed: 9989313
Int J Psychol. 2008 Dec;43(6):958-68
pubmed: 22022839
N Engl J Med. 1998 Jan 15;338(3):171-9
pubmed: 9428819
Biol Psychol. 1990 Oct;31(2):157-71
pubmed: 1983313
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):899-902
pubmed: 19409951
Eur Neuropsychopharmacol. 2009 May;19(5):349-55
pubmed: 19223156
J Psychiatr Res. 2011 Aug;45(8):995-1004
pubmed: 21550050
Neuroscience. 2013 Jun 3;239:149-56
pubmed: 23402850
Lancet. 1997 Jul 26;350(9073):235-9
pubmed: 9242799
J Dent Res. 2006 Sep;85(9):844-8
pubmed: 16931869
J Endocrinol. 2008 May;197(2):429-35
pubmed: 18434373
BMC Fam Pract. 2015 Mar 19;16:38
pubmed: 25880219
Neurosci Lett. 2002 Aug 16;328(3):261-4
pubmed: 12147321
Neurochem Res. 2010 May;35(5):830-4
pubmed: 20119637
J Occup Health Psychol. 1998 Oct;3(4):322-55
pubmed: 9805280
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12320-2
pubmed: 11675480
Stress. 2010 Jan;13(1):53-60
pubmed: 19658028
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Biol Psychol. 1996 Feb 5;42(3):425-38
pubmed: 8652757
Am J Psychiatry. 2003 Aug;160(8):1516-8
pubmed: 12900317
Psychiatry Clin Neurosci. 2013 Jul;67(5):363-4
pubmed: 23859665
Neuropsychobiology. 2010;62(4):207-12
pubmed: 20714169
J Neurochem. 2004 Nov;91(4):843-51
pubmed: 15525338
Biol Psychiatry. 2008 Sep 15;64(6):527-32
pubmed: 18571629
J Affect Disord. 2015 Jan 15;171:167-70
pubmed: 25305432
Neuropharmacology. 1998 Dec;37(12):1553-61
pubmed: 9886678
Psychosomatics. 1971 Nov-Dec;12(6):371-9
pubmed: 5172928
Curr Opin Cell Biol. 2011 Dec;23(6):730-7
pubmed: 21996102
J Psychiatry Neurosci. 2009 Jan;34(1):4-20
pubmed: 19125209
Psychopharmacol Bull. 1973 Jan;9(1):13-28
pubmed: 4682398
Brain Behav. 2019 Jul;9(7):e01298
pubmed: 31197968
Neuropsychopharmacology. 2008 Jan;33(1):88-109
pubmed: 17851537
Biol Psychol. 2009 Mar;80(3):265-78
pubmed: 19022335
Endocrinology. 2011 Dec;152(12):4496-503
pubmed: 21971152
Psychiatry Res. 2011 Apr 30;186(2-3):326-32
pubmed: 20832122
J Psychiatr Res. 2007 Oct;41(7):600-5
pubmed: 16600301
Hum Reprod. 2007 Apr;22(4):995-1002
pubmed: 17251358
Neurosci Lett. 2009 Dec 11;466(3):139-43
pubmed: 19786073
J Affect Disord. 2008 Jan;105(1-3):279-83
pubmed: 17553570
J Affect Disord. 2015 Mar 15;174:432-40
pubmed: 25553404
Neurobiol Aging. 2005 Jan;26(1):115-23
pubmed: 15585351

Auteurs

Rodolfo Buselli (R)

Occupational Health Department, U.O. Medicina Preventiva del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Antonello Veltri (A)

Unità Operativa Complessa Psichiatria di Pisa, Dipartimento della Salute Mentale e Dipendenze, Azienda USL Toscana Nord Ovest, Pisa, Italy.
Fondazione BRF Onlus-Institute for Research in Psychiatry and Neuroscience, Lucca, Italy.

Sigrid Baldanzi (S)

Occupational Health Department, U.O. Medicina Preventiva del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Riccardo Marino (R)

Occupational Health Department, U.O. Medicina Preventiva del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Alessandra Bonotti (A)

Occupational Health Department, U.O. Medicina Preventiva del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Martina Chiumiento (M)

Occupational Health Department, U.O. Medicina Preventiva del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Michelle Girardi (M)

Occupational Health Department, U.O. Medicina Preventiva del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Luca Pellegrini (L)

Occupational Health Department, U.O. Medicina Preventiva del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Giovanni Guglielmi (G)

Occupational Health Department, U.O. Medicina Preventiva del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Liliana Dell'Osso (L)

Section of Psychiatry, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Alfonso Cristaudo (A)

Occupational Health Department, U.O. Medicina Preventiva del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH